Please assess the completion status of the following clinical trial:

Trial Title: Immunogenicity of HPV Vaccine in Immunosuppressed Children

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~- Immunosuppressed patients with following diseases; Bone marrow transplant recipients, liver transplant patients, renal transplant, Children with inflammatory bowel disease, juvenile Idiopathic arthritis and autoimmune conditions.~Exclusion Criteria:~* A platelet count of \<50~* Immunoglobulin therapy within 3 months.~* Yeast allergy~* Any other known allergies to one of the vaccine component

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- HPV vaccine (Type: EXPERIMENTAL): Quadrivalent HPV vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).